# ALL Adult Consortium Trial: Adult ALL Trial

> **NCT00476190** · PHASE2 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 112 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** Doxorubicin
- **DRUG:** Cytarabine
- **DRUG:** Methotrexate
- **DRUG:** Vincristine
- **DRUG:** Cyclophosphamide
- **DRUG:** Methylprednisone
- **DRUG:** Hydrocortisone Sodium Succinate
- **DRUG:** Dexamethasone
- **DRUG:** 6-MP
- **DRUG:** PEG-Asparaginase
- **DRUG:** Imatinib
- **DRUG:** Etoposide
- **PROCEDURE:** Radiation Therapy
- **DRUG:** E. coli Asparaginase

## Key facts

- **NCT ID:** NCT00476190
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2013-09
- **Final completion:** 2020-03
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2025-06-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00476190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00476190, "ALL Adult Consortium Trial: Adult ALL Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00476190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*